Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
Clinical trial NCT07427394 · RECRUITING
Trial details
- NCT number
- NCT07427394
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-06
- Primary completion
- 2027-12-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.